This content is machine translated Long COVID/Fatigue Clinic An Innovative Approach: Neuroplasticity and Predictive Processing At the University Hospital of Basel (USB), a promising neuroplastic therapeutic approach is being tested as part of the fatigue clinic. Based on the fundamental assumption that while fatigue and...…
View Post 6 min This content is machine translated Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib First-class immunomodulation combined with convenience—the data available so far is convincing Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active...…
View Post 6 min This content is machine translated Myasthenia gravis: immunomodulatory therapies for long-term treatment Expanded Possibilities Thanks to Innovative Classes of Active Ingredients Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed...…
View Post 7 min This content is machine translated Ischemic stroke: Are smaller or larger brain arteries affected? Recent study findings on intravenous lysis therapy with fibrinolytic agents Intravenous thrombolysis, with or without mechanical thrombectomy, is a key pillar in the treatment of ischemic stroke. There are now two approved treatment options available—alteplase and tenecteplase—and Phase II data...…
View Post 5 min This content is machine translated Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer? Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs In addition to the EULAR (European Alliance of Associations for Rheumatology)/ACR (American College of Rheumatology) classification criteria, there are other validated tools that facilitate the early detection of SLE, such...…
View Post 4 min This content is machine translated Non-small-cell lung cancer (NSCLC) Long-term data from the CROWN study: Efficacy and intracranial control Updated 7-year data from the CROWN study were presented at the 2026 ASCO Annual Meeting. These data confirm stable long-term disease control with lorlatinib and reinforce its role as a...…
View Post 6 min This content is machine translated Malignant oral squamous cell carcinomas (OPSCC/HNSCC) Innovative Treatment Options The latest data from the AREST study, presented at the 2026 ASCO Annual Meeting, demonstrate that adjuvant radiation therapy following curative surgery for early-stage oral squamous cell carcinoma significantly improves...…
View Post 3 min This content is machine translated Advanced solid tumors Survival Plateaus with Botensilimab + Balstilimab At the 2025 ESMO Congress, a wealth of data on solid tumors was presented. This included an updated analysis of the combination of botensilimab and balstilimab.... Dieser Inhalt ist nur…
View Post 6 min This content is machine translated Soft-tissue sarcomas of the upper extremities Immunotherapy and Molecular Targets New immunotherapy strategies for soft tissue sarcomas were presented at the 2026 ASCO Annual Meeting. The focus was on biomarker-based approaches using pembrolizumab and PD-L1 inhibition, which are also gaining...…
View Post 6 min This content is machine translated C3 glomerulopathy—can its progression be halted? Iptacopan and Pegcetacoplan Open Up New Horizons To diagnose C3 glomerulopathy (C3G) and distinguish it from other membranoproliferative glomerulopathies, a kidney biopsy is required in addition to measuring the concentration of the complement protein C3 in the...…
View Post 6 min This content is machine translated CKD: Cardiorenal Benefits of nsMRA and GLP-1RA FIND-CKD and FLOW: Benefits Across Heterogeneous Patient Populations Finerenon significantly slowed the decline in kidney function in non-diabetic adults with chronic kidney disease (CKD) and also reduced the risk of cardiovascular complications —according to recently published data from...…
